Comments on Proposed Rule Regarding Approach to PFAS Reporting Requirements and Supplier Notification for Chemicals of Special Concern Share page: Docket Number: EPA–HQ–TRI–2022–0270 Download Document Issues: OTC Medicines Dietary Supplements OTC Medical Devices Other Issues Packaging Sustainability PFAS Related Posts Press Releases and Statements CHPA Commends Lawmakers for Urging FDA to Protect the Rx-OTC-Switch Pathway Apr 11, 2025 Press Releases and Statements House Leaders Prioritize OMUFA Renewal, CHPA Welcomes Progress Apr 1, 2025 Press Releases and Statements CHPA Statement on Senate Confirmation of Dr. Makary as FDA Commissioner Mar 25, 2025